[
  {
    "ts": "2026-02-08T02:50:00+00:00",
    "headline": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
    "summary": "Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.",
    "url": "https://www.fool.com/investing/2026/02/07/missed-out-on-eli-lilly-2-healthcare-stocks-with-b/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "a08c7e4e-8a72-3a9a-b75a-cde4b13f162d",
      "content": {
        "id": "a08c7e4e-8a72-3a9a-b75a-cde4b13f162d",
        "contentType": "STORY",
        "title": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
        "description": "",
        "summary": "Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.",
        "pubDate": "2026-02-08T02:50:00Z",
        "displayTime": "2026-02-08T02:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/383956ea2a3a89f7dac1614dd83af11c",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "A person standing with a u turn sign on the ground in front of them.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lk9o0Tx5YvpuHb5Qc06p6g--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/383956ea2a3a89f7dac1614dd83af11c.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BjS5VenDjPwIxE625D2yzQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/383956ea2a3a89f7dac1614dd83af11c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/07/missed-out-on-eli-lilly-2-healthcare-stocks-with-b/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/missed-eli-lilly-2-healthcare-025000620.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-08T10:05:00+00:00",
    "headline": "Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology",
    "summary": "Innovent Biologics, Inc. (\"Innovent\") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Company (\"Lilly\") to advance novel medicines in oncology and immunology. This agreement marks the seventh collaboration between the two companies, deepening a",
    "url": "https://finance.yahoo.com/news/innovent-announces-strategic-collaboration-lilly-100500309.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "34b5a86a-bf34-365b-918c-eba3e2090535",
      "content": {
        "id": "34b5a86a-bf34-365b-918c-eba3e2090535",
        "contentType": "STORY",
        "title": "Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology",
        "description": "",
        "summary": "Innovent Biologics, Inc. (\"Innovent\") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Company (\"Lilly\") to advance novel medicines in oncology and immunology. This agreement marks the seventh collaboration between the two companies, deepening a",
        "pubDate": "2026-02-08T10:05:00Z",
        "displayTime": "2026-02-08T10:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/9ffd7989dfba6052a90df6efa1d987f0",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ff3oWoarY5PF9WTlrryYRw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/9ffd7989dfba6052a90df6efa1d987f0.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0.nAM34y0RYphEhkxzt1Fg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9ffd7989dfba6052a90df6efa1d987f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/innovent-announces-strategic-collaboration-lilly-100500309.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/innovent-announces-strategic-collaboration-lilly-100500309.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IVBIY"
            },
            {
              "symbol": "IVBXF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-08T12:08:32+00:00",
    "headline": "Eli Lilly Ties TrumpRx Pricing To GLP-1 Growth And New Therapies",
    "summary": "Eli Lilly (NYSE:LLY) has joined the Trump administration’s TrumpRx program to provide discounted pricing on select high demand therapies in the U.S. The company announced new collaborations focused on autoimmune diseases and hearing loss, targeting large patient populations with unmet medical needs. Lilly is moving ahead with multibillion dollar U.S. manufacturing expansion, including an advanced facility in Pennsylvania, to support next generation medicines. Eli Lilly sits at the center of...",
    "url": "https://finance.yahoo.com/news/eli-lilly-ties-trumprx-pricing-120832374.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "892b8eb5-2b62-3d2c-a14f-f2d158e8e2ac",
      "content": {
        "id": "892b8eb5-2b62-3d2c-a14f-f2d158e8e2ac",
        "contentType": "STORY",
        "title": "Eli Lilly Ties TrumpRx Pricing To GLP-1 Growth And New Therapies",
        "description": "",
        "summary": "Eli Lilly (NYSE:LLY) has joined the Trump administration’s TrumpRx program to provide discounted pricing on select high demand therapies in the U.S. The company announced new collaborations focused on autoimmune diseases and hearing loss, targeting large patient populations with unmet medical needs. Lilly is moving ahead with multibillion dollar U.S. manufacturing expansion, including an advanced facility in Pennsylvania, to support next generation medicines. Eli Lilly sits at the center of...",
        "pubDate": "2026-02-08T12:08:32Z",
        "displayTime": "2026-02-08T12:08:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-ties-trumprx-pricing-120832374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-ties-trumprx-pricing-120832374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]